| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000049230 |
| Receipt No. | R000056068 |
| Scientific Title | Prospective randomized trial of clinical outcomes of angiography-based fractional flow reserve guidance versus wire-based fractional flow reserve guidance |
| Date of disclosure of the study information | 2022/10/16 |
| Last modified on | 2022/10/16 (Ver. 1) |
| Basic information | ||
| Public title | Prospective randomized trial of clinical outcomes of angiography-based fractional flow reserve guidance versus wire-based fractional flow reserve guidance | |
| Acronym | PROVISION study | |
| Scientific Title | Prospective randomized trial of clinical outcomes of angiography-based fractional flow reserve guidance versus wire-based fractional flow reserve guidance | |
| Scientific Title:Acronym | PROVISION study | |
| Region |
|
|
| Condition | ||
| Condition | coronary artery disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the revascularization rate based on angiography-derived fractional flow reserve compared to that based on angiography-derived fractional flow reserve. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Revascularization rate based on angiography-derived fractional flow reserve compared to that based on fractional flow reserve |
| Key secondary outcomes | Adverse events after one year(cardiac death, myocardial infarction, ischemia-driven revascularization, stroke, hospitalization due to heart failure)
Costs of cardiac catheterization and revascularization Costs of adverse events |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Treatment based on FFRangio asesssment | |
| Interventions/Control_2 | Treatment based on FFR asessment | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patients for whom PCI is appropriate
2)Lesions whose visual diameter stenosis is greater than or equal to 30% and less than 90% 3)Lesions whose visual reference vessel diameter is greater than or equal to 2mm |
|||
| Key exclusion criteria | 1)Patients for whom PCI is not appropriate
2)Patients with within 72 hours of acute coronary syndrome 3)Patients with severe bronchial asthma or chronic obstructive pulmonary disease 4)Patients with heart failure categorized as NYHA class III or IV 5)Patients with allergy to contrast media |
|||
| Target sample size | 400 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Gifu Heart Center | ||||||
| Division name | Cardiology | ||||||
| Zip code | 500-8384 | ||||||
| Address | 4-14-4 Yabutaminami, Gifu city, Gifu | ||||||
| TEL | 058-277-2277 | ||||||
| matsuo@heart-center.or.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Gifu Heart Center | ||||||
| Division name | Cardiology | ||||||
| Zip code | 500-8384 | ||||||
| Address | 4-14-4 Yabutaminami, Gifu city, Gifu | ||||||
| TEL | 058-277-2277 | ||||||
| Homepage URL | |||||||
| tanigaki@heart-center.or.jp | |||||||
| Sponsor | |
| Institute | Gifu Heart Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Gifu Heart Center |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Gifu Heart Center Institutional Review Board |
| Address | 4-14-4 Yabutaminami, Gifu city, Gifu |
| Tel | 058-277-2277 |
| tomita@heart-center.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 400 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056068 |